Anika Therapeutics logo

Anika Therapeutics Share Price Today

(NASDAQ: ANIK)

Anika Therapeutics share price is $15.42 & ₹1,325.86 as on 21 Mar 2025, 09.30 hrs IST

$15.42

-0.2

(-1.28%)

Market is closed - opens 7 PM, 24 Mar 2025

View live Anika Therapeutics share price in Dollar and Rupees. Guide to invest in Anika Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Anika Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Anika Therapeutics share price movements

  • Today's Low: $15.30
    Today's High: $15.74

    Day's Volatility :2.83%

  • 52 Weeks Low: $14.95
    52 Weeks High: $29.12

    52 Weeks Volatility :48.65%

Anika Therapeutics (ANIK) Returns

PeriodAnika Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-4.99%
5.7%
0.0%
6 Months
-38.37%
-5.1%
0.0%
1 Year
-38.54%
0.8%
0.0%
3 Years
-42.05%
9.4%
-13.8%

Anika Therapeutics (ANIK) Key Statistics

in dollars & INR

Previous Close
$15.62
Open
$15.44
Today's High
$15.74
Today's Low
$15.295
Market Capitalization
$218.6M
Today's Volume
$127.9K
52 Week High
$29.115
52 Week Low
$14.95
Revenue TTM
$119.9M
EBITDA
$3.6M
Earnings Per Share (EPS)
$-0.6
Profit Margin
-47.02%
Quarterly Earnings Growth YOY
-0.5%
Return On Equity TTM
-4.82%

How to invest in Anika Therapeutics Stock (ANIK) from India?

It is very easy for Indian residents to invest directly in Anika Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Anika Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Anika Therapeutics or ANIK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Anika Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Anika Therapeutics shares which would translate to 0.056 fractional shares of Anika Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Anika Therapeutics, in just a few clicks!

Returns in Anika Therapeutics (ANIK) for Indian investors in Rupees

The Anika Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Anika Therapeutics investment value today

Current value as on today

₹64,652

Returns

₹35,348

(-35.35%)

Returns from Anika Therapeutics Stock

₹38,541 (-38.54%)

Dollar Returns

₹3,194 (+3.19%)

Indian investors sentiment towards Anika Therapeutics (ANIK)

-40%

Period: Feb 20, 2025 to Mar 22, 2025. Change in 30 Days versus previous period

Search interest for Anika Therapeutics Stock from India on INDmoney has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Anika Therapeutics

  • Trigran Investments Inc

    13.80%

  • BlackRock Inc

    10.64%

  • Caligan Partners LP

    9.80%

  • Vanguard Group Inc

    5.23%

  • Alta Fundamental Advisers LLC

    4.78%

  • Dimensional Fund Advisors, Inc.

    4.49%

Analyst Recommendation on Anika Therapeutics

Buy

    77%Buy

    22%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Anika Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Anika Therapeutics Stock (ANIK)

What analysts predicted

Upside of 55.64%

Target:

$24.00

Current:

$15.42

Insights on Anika Therapeutics Stock (Ticker Symbol: ANIK)

  • Price Movement

    In the last 7 days, ANIK stock has moved down by -3.1%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 41.92M → -1.29M (in $), with an average decrease of 55.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -29.91M → -21.86M (in $), with an average increase of 36.8% per quarter
  • ANIK vs ITCI (1 yr)

    In the last 1 year, Intra-cellular Therapies, Inc. has given 90.7% return, outperforming this stock by 130.1%
  • ANIK vs ITCI (3 yr)

    In the last 3 years, Intra-cellular Therapies, Inc. has given 121.3% return, outperforming this stock by 162.4%
  • Price to Sales

    ForANIK every $1 of sales, investors are willing to pay $1.9, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

Anika Therapeutics Technicals Summary

Sell

Neutral

Buy

Anika Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Anika Therapeutics (ANIK) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Anika Therapeutics Inc logo
-11.33%
-38.37%
-38.54%
-42.05%
-44.23%
Intra-cellular Therapies, Inc. logo
2.37%
73.66%
93.69%
121.67%
762.15%
Haleon Plc Spon Ads logo
1.98%
-3.29%
21.95%
38.73%
38.73%
Zoetis Inc. logo
1.6%
-15.79%
-2.85%
-14.0%
57.12%
Viatris Inc. logo
-18.67%
-20.23%
-22.65%
-16.44%
-44.0%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Anika Therapeutics Inc logo
NA
NA
5.04
0.31
-0.05
-0.01
NA
10.68
Intra-cellular Therapies, Inc. logo
NA
NA
0.0
0.13
-0.09
-0.07
NA
10.81
Haleon Plc Spon Ads logo
25.7
25.7
1.86
0.37
0.09
0.04
0.02
1.8
Zoetis Inc. logo
29.86
29.86
2.88
6.07
0.51
0.15
0.01
10.64
Viatris Inc. logo
224.4
NA
0.15
2.2
-0.03
0.02
0.05
15.61
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Anika Therapeutics Inc logo
Buy
$218.6M
-44.23%
NA
-47.02%
Intra-cellular Therapies, Inc. logo
Buy
$14.0B
762.15%
NA
-10.97%
Haleon Plc Spon Ads logo
Buy
$46.5B
38.73%
25.7
12.84%
Zoetis Inc. logo
Buy
$73.1B
57.12%
29.86
26.86%
Viatris Inc. logo
Hold
$11.3B
-44.0%
224.4
-4.3%

About Anika Therapeutics

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short-and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions. In addition, the company offers non-orthopedic products comprising HA-based products for Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Organization
Anika Therapeutics
Employees
288
CEO
Dr. Cheryl Renee Blanchard Ph.D.
Industry
Health Technology

Management People of Anika Therapeutics

NameTitle
Dr. Cheryl Renee Blanchard Ph.D.
President, CEO & Director
Ms. Anne Nunes
Senior VP & COO
Mr. David Colleran J.D.
Executive VP, General Counsel & Corporate Secretary
Mr. Ian W. McLeod
VP & Chief Accounting Officer
Mr. Mark Namaroff
Vice President of Investor Relations, ESG & Corporate Communications
Mr. James Chase
Senior Vice President of International Sales & Marketing
Mr. Ben Joseph
Vice President of Commercial & Corporate Development
Ms. Lisa Funiciello
Vice President of Human Resources

Important FAQs about investing in ANIK Stock from India :

What is Anika Therapeutics share price today?

Anika Therapeutics share price today stands at $15.42, Open: $15.44 ; Previous Close: $15.62 ; High: $15.74 ; Low: $15.30 ; 52 Week High: $29.12 ; 52 Week Low: $14.95.

The stock opens at $15.44, after a previous close of $15.62. The stock reached a daily high of $15.74 and a low of $15.30, with a 52-week high of $29.12 and a 52-week low of $14.95.

Can Indians buy Anika Therapeutics shares?

Yes, Indians can invest in the Anika Therapeutics (ANIK) from India.

With INDmoney, you can buy Anika Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Anika Therapeutics at zero transaction cost.

How can I buy Anika Therapeutics shares from India?

It is very easy to buy Anika Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Anika Therapeutics (ANIK) be purchased?

Yes, you can buy fractional shares of Anika Therapeutics with INDmoney app.

What are the documents required to start investing in Anika Therapeutics stocks?

To start investing in Anika Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Anika Therapeutics Stock (ANIK)?

Today’s highest price of Anika Therapeutics (ANIK) is $15.74.

Today’s lowest price of Anika Therapeutics (ANIK) is $15.30.

What is today's market capitalisation of Anika Therapeutics?

Today's market capitalisation of Anika Therapeutics ANIK is 218.6M

What is the 52 Week High and Low Range of Anika Therapeutics Stock (ANIK)?

  • 52 Week High

    $29.12

  • 52 Week Low

    $14.95

What are the historical returns of Anika Therapeutics (ANIK)?

  • 1 Month Returns

    -11.33%

  • 3 Months Returns

    -38.37%

  • 1 Year Returns

    -38.54%

  • 5 Years Returns

    -44.23%

Who is the Chief Executive Officer (CEO) of Anika Therapeutics ?

Dr. Cheryl Renee Blanchard Ph.D. is the current Chief Executive Officer (CEO) of Anika Therapeutics.